Reactions To The Dee Gordon Suspension

Here’s a roundup of reactions to Marlins star Dee Gordon‘s shocking 80-game PED suspension.

  • That a speedy player like Gordon would get busted for PED use might seem surprising, but PED use isn’t just about power, it’s about endurance and maximizing small edges, ESPN’s Doug Glanville writes. Glanville relates that, as a former player, he felt exhausted at the end of a long season, and he adds that other players do as well. A fast singles hitter might feel the temptation to take PEDs in order to get through the grind, according to Glanville.
  • That written, some within the game were shocked by Gordon’s suspension, as Glanville’s colleague Jayson Stark notes. The news was particularly surprising given that Gordon had already signed a long-term deal. “This is the single most bizarre case I’ve ever come across, because he tested positive after signing a $50 million contract,” says one team exec. “He could have hit .220 and never stolen another base, and he still would have gotten paid for the next five years.” Stark further notes that the proliferation of PED busts so far this year — Chris Colabello, Abraham Almonte, Jenrry Mejia, and so on — shows that testing is improving.
  • Gordon isn’t to be pitied for his actions, but MLB’s culture is perhaps too forgiving of PED users, Joel Sherman of the New York Post writes. Gordon will still receive the bulk of the money his contract promises him. Other players accused of PED use, like Nelson Cruz, have received lengthy contracts later, while still others, like Barry Bonds and Mark McGwire, have returned as coaches. And — as Stark and Sherman both note — MLB’s brutal, travel-heavy schedules motivate players to take PEDs as well.
  • Members of the players union are considering increasing penalties for players who test positive for PEDs, writes John Shea of the San Francisco Chronicle. Gordon and Colabello “are established guys,” says Athletics closer and player rep Sean Doolittle. “These aren’t guys fighting for a spot or going up and down. These are guys who are hitting over .300. We thought we ratcheted (the drug policy) up enough, and apparently we haven’t.” Doolittle adds that the players are considering ways to steepen the financial penalties for busted players — a player who tests positive might lose his salary for an entire year, for example. Doolittle notes, though, that voiding an entire contract might be problematic, in that such a steep penalty could suddenly give a player’s team an immense amount of money to spend, effectively hurting other teams competing for free agent talent.
  • MLB and the players union will have “no choice” but to increase PED penalties in the next collective bargaining agreement, USA Today’s Bob Nightengale writes. Perhaps the penalty for a first offense could increase to a full-season ban, with the second offense earning a lifetime ban, Nightengale suggests.

AL Pitcher Notes: Wilson, Skaggs, Greene

While the Tigers picked up left-hander Justin Wilson in a trade this offseason with the Yankees, they weren’t the only AL Central club to attempt to acquire him. The Twins, too, made what they considered to be an aggressive offer to acquire Wilson and were surprised that their proposal was rejected in favor of Detroit’s package of right-handers Chad Green and Luis Cessareports Mike Berardino of the St. Paul Pioneer Press. Twins GM Terry Ryan wouldn’t offer any details into his club’s pursuit, though he did confirm that he was well aware that Wilson was available prior to his trade. Of course, the Twins’ alternative has worked out quite well for them to date, Berardino notes. Minnesota picked up Fernando Abad on a minor league deal, and an improved changeup (Abad terms it a “super changeup,” as he’ll throw it as slow as 65 mph) has yielded dominant results: zero earned runs, four hits, three walks, 12 strikeouts and a 55 percent ground-ball rate in 9 2/3 innings. Here are more notes on American League pitchers.

  • The Angels are having Tyler Skaggs fly back to Los Angeles to evaluate his shoulder, MLB.com’s Alden Gonzalez writes. Skaggs, who is recovering after having Tommy John surgery late in the 2014 season, made three rehab starts with Triple-A Salt Lake this month before being scratched last week due to what was initially described as “fatigue” but now appears to be shoulder tightness — a problem that would seem to be at least somewhat distinct from the elbow trouble that initially ailed him. Before his elbow injury, Skaggs was establishing himself as a solid young starting pitching option. It sounds like it might be a bit longer, at least, before he returns to where he was.
  • Yesterday, the Tigers placed righty Shane Greene on the 15-day DL with a blister on his right middle finger, Anthony Fenech of the Detroit Free Press tweets. In four appearances this year, the 27-year-old Greene has continued to struggle as he did throughout much of the 2015 season, and he now has a 6.80 ERA, 5.6 K/9 and 3.3 BB/9 in 98 career innings since the Tigers acquired him in the three-team Didi Gregorius / Robbie Ray trade in the 2014-15 offseason. Top prospect Michael Fulmer started in Greene’s place yesterday.

Week In Review: 4/23/16 – 4/29/16

Here’s a look back at the past week at MLBTR.

Key Moves

Top Prospect Promotions

Claimed

Designated For Assignment

Outrighted

Released

Retired

Key Minor League Signings

AL East Notes: Mirabelli, Bautista, Kiermaier, Lohse

Tim Healey of The Hardball Times paints a fascinating portrait of an oddball deal in a deep look at the Red Sox’ 2006 re-acquisition of catcher Doug Mirabelli from the Padres. Truth be told, I don’t have any observations on the piece other than that it demands to be read and is well worth your time.

Here are a few notes from the AL East:

  • MLB Network’s Jon Heyman tweets that while he believes Blue Jays slugger Jose Bautista would take less than his reported asking price of more than $150MM over five to six years, he doesn’t believe Bautista would entertain any offers for less than $100MM. Bautista’s alleged asking price was the source of a great deal of controversy in Spring Training, and while $150MM+ doesn’t seem particularly realistic, he would probably have a strong case for $100MM on the open market this winter. Bautista may be 35, but he’s been remarkably consistent since his 2010 breakout and is off to a strong start, batting .247/.394/.519 with four homers and an AL-leading 20 walks drawn.
  • In other extension-related news, the Rays have not seriously engaged with center fielder Kevin Kiermaier about a deal over the last several months, according to Chris Cotillo of SB Nation (Twitter link). Nevertheless, Tampa Bay has given some indication of interest at some point. The 26-year-old seems like the type of player the Rays would target for a bargain contract, as he had only accumulated 1.131 years of service entering the season and is a glove-first player whose on-field value may not translate particularly well into arbitration earnings. Even if he can’t replicate last year’s magical season in the field, he seems like a good bet to continue as a solid asset for years to come. While it seems unlikely that the sides will get anything started in the near term, last year’s Juan Lagares extension looks like as good a comp as one could hope for. Lagares was the same age and featured a similar profile, though he was much more certain at the time to reach Super Two status (and, it’s fair to note, has done less with the bat in his career).
  • Even after adding veteran Wandy Rodriguez, the Orioles continue to stay in touch with righty Kyle Lohse, Dan Connolly of BaltimoreBaseball.com reports. As we’ve heard previously, Baltimore has made an offer to Lohse but, obviously, has yet to reach agreement. It’s still not clear what the 37-year-old is prioritizing in deciding upon a club with which to attempt a bounceback, but the O’s rotation certainly seems to offer a reasonable likelihood of opportunity over the coming months.

West Notes: Hahn, Bassitt, Gutierrez, McCullers

After giving Sean Manaea his first start tonight, the Athletics will recall right-hander Jesse Hahn from Triple-A Nashville to start tomorrow’s game against the Astros, reports Susan Slusser of the San Francisco Chronicle. The 26-year-old spent much of the 2015 season in Oakland’s rotation after coming over from the Padres in the Derek Norris trade, but his season was cut short by an injured right flexor tendon and a woeful Spring Training landed him in Triple-A. Hahn has recorded a 2.04 ERA in four starts with Nashville this season, though he hasn’t been as dominant as that mark might initially suggest. Hahn has lasted a total of 17 2/3 innings in those four outings with a 13-to-9 K/BB ratio.

More from the American League…

  • The Athletics‘ rotation has struggled of late, and now right-hander Chris Bassitt is heading to the DL after seeing his velocity dip from 92-94 mph to 89-90 mph in his most recent start. He’s been diagnosed with an elbow sprain, Slusser tweets, but there are some worrying indications. As MLB.com’s Jane Lee reports, Bassitt says he’s struggling with more than just his velocity, and indicated that he’s been quietly dealing with elbow discomfort for some time. “I didn’t want to say anything because I’ve worked harder than I ever have this offseason,” Bassitt said. “I felt so excited and prepared going into this season, and for this to happen, it really sucks. The way I’m feeling right now, I can’t throw right now.”
  • The Astros and Dodgers had the most notable scouting entourages on hand to watch Cuban righty Vladimir Gutierrez in what will likely be his final showcase, Baseball America’s Ben Badler reports. There were plenty of other organizations with eyes on Gutierrez, of course, so one shouldn’t read too much into that. Generally, says Badler, the interesting youngster showed a mid-90s fastball and impressive breaking ball, though his fastball command and other offerings still need work.
  • Astros righty Lance McCullers Jr. is ready for a sixty to seventy-five pitch outing in his next extended spring work, Jake Kaplan of the Houston Chronicle reports on Twitter. That certainly seems to indicate that he could be nearing a rehab stint, which would be good news for a Houston club that badly misses his high-octane arm in the rotation.

NL Central Notes: Pirates, Bryant, Arrieta, Jungmann

The Pirates announced on Friday that they have extended their entire coaching staff through the 2017 season. The club did not announce a new contract for skipper Clint Hurdle, though Hurdle was already signed through the 2017 season himself, whereas the coaches’ contracts ran through the end of the current campaign. The new contracts mean that bench coach Dave Jauss, pitching coach Ray Searage, hitting coach Jeff Branson, third base coach Rick Sofield, first base coach Nick Leyva, bullpen coach Euclides Rojas, assistant hitting coach Jeff Livesey and bullpen catcher Heberto Andrade will all return for another season. Searage, in particular, has become particularly notable in the national media due to Pittsburgh’s success in rehabilitating pitchers that have endured recent struggles (though the Bucs did lose noted pitching specialist Jim Benedict to the Marlins’ front office this past winter).

A few more notes out of the NL Central…

  • Cubs third baseman Kris Bryant underwent an MRI this morning which confirmed that his right ankle sprain is mild in nature, writes MLB.com’s Carrie Muskat. Bryant is out of the lineup today in favor of Javier Baez and may miss a few games, tweets Paul Sullivan of the Chicago Tribune, but the reigning National League Rookie of the Year isn’t expected to require a trip to the disabled list and should be back in relatively short order. Obviously, that’s good news for a Cubs team that has already lost Kyle Schwarber for the season and had to place catcher Miguel Montero on the 15-day disabled list yesterday.
  • As we’ve heard recently, the Cubs and ace Jake Arrieta remain far apart in extension talks. MLB Network’s Jon Heyman (via Twitter) says that Arrieta remains focused on securing a seven-year deal, as was the case back in Spring Training, but the team is currently only comfortable with offering the reigning Cy Young winner a four-year extension. That type of deal would run through Arrieta’s age-34 season, whereas Arrieta’s preferred contract length would extend into his age-37 campaign. Dominant as he may be, it’s understandable that the Cubs are hesitant to guarantee both Arrieta such a substantial amount through age 37, especially considering the fact that with free agency about 18 months away and a huge salary already in the bank, Arrieta and agent Scott Boras probably don’t feel the need to offer a considerable discount in terms of average annual value. Beyond that, the Cubs are already paying Jon Lester into his age-36 season, and promising that type of cash to a pair of pitchers into their late 30s is wrought with risk for the team.
  • Though he started the Brewers‘ third game of the season, right-hander Taylor Jungmann was optioned to Triple-A by Milwaukee today, the team announced. The 26-year-old made a very strong debut in 2015, logging 119 1/3 innings with a 3.77 ERA, 8.1 K/9, 3.5 BB/9 and a 46.3 percent ground-ball rate, but he’s struggled tremendously in 2016. Thus far, Jungmann has yielded 21 earned runs in 20 2/3 innings, and he’s walked as many batters as he’s struck out (13). His velocity is also down two and a half miles per hour from last season. The Brewers called up reliever David Goforth in the interim, but they’ll need to make a move to add another starter in advance of Jungmann’s next would-be turn in the rotation, which would come on Tuesday. As MLB.com’s Adam McCalvy points out (on Twitter), Jungmann now faces the unenviable task of attempting to find the solution to his struggles in one of the game’s least-favorable pitching environments: Colorado Springs.

Sam Fuld Will Miss Season After Rotator Cuff Surgery

Athletics outfielder Sam Fuld requires surgery on a torn rotator cuff, MLB.com’s Jane Lee reports on Twitter. He’ll undergo the procedure on May 18 and will not be ready to return during the 2016 season.

Fuld, a 34-year-old veteran of eight MLB campaigns, avoided arbitration with Oakland at a $1.93MM salary. He’ll continue to accrue service while he’s shelved, and will qualify for free agency after the season.

While he’s seen fairly consistent reserve action since 2011, Fuld has never been very productive with the bat. He owns a .227/.307/.325 career slash line over 1,535 plate appearances. He does add some value with his legs, with 67 career stolen bases and generally excellent baserunning metics. Most of all, Fuld has long been known as a quality defender, with advanced metrics placing strong ratings on his work in left and center.

Oakland would surely have preferred to have Fuld as a depth option, but doesn’t have a particulary strong need for him at present. Indeed, the team’s addition of Chris Coghlan — like Fuld, a left-handed hitter — seemed to occupy his most obvious place in the organization.

Grant Balfour Retires

Longtime MLB reliever Grant Balfour has officially wrapped up his 12-year MLB career, he tells Marc Topkin of the Tampa Bay Times. Balfour, 38, last pitched briefly in early 2015 with the Rays.

Last we checked in, Balfour expressed interest in continuing to pitch. Of course, that was at the end of May of 2015, and he hasn’t appeared in the majors since being cut loose by Tampa Bay. The veteran tells Topkin that he mulled a return this spring, but decided not to look for a spring invite after beginning to throw.

“It was honestly a great ride, meeting a lot of people and developing friendships along the way,” said the Australian native. “I now look forward to sitting home and being a spectator and be able to spend more time with my family.”

Balfour took some time establishing himself in the majors, but had a nice run of success once he did. Between 2008 and 2013, Balfour run up 380 1/3 innings of 2.74 ERA pitching with 9.7 K/9 against 3.5 BB/9. That made him one of the most reliable pen arms in baseball; eventually, Balfour would take over the Athletics’ closer role, picking up 62 saves in the final two years of that solid stretch of pitching.

After wrapping up a strong three-year run in Oakland, Balfour returned to the Rays after a deal with the division-rival Orioles fell apart over his physical. That represented a homecoming for the reliever, who had finally locked down a steady MLB job in Tampa Bay after prior stints with the Twins and Brewers.

Unfortunately, Balfour didn’t make good on his two-year contract, with age, velocity decline, and control issues telling in the results. Balfour ended 2014 with a 4.91 ERA in 62 1/3 frames, and was removed from the roster just six appearances into 2015 after failing to record strikeout and allowing three runs in 4 1/3 innings. He signed a minor league deal to stay with the Rays organization, and ultimately made eight Triple-A appearances, but didn’t experience enough improvement to make it back to the bigs.

MLBTR congratulates Balfour on his career and wishes him the best in his future endeavors.

PED Incentives And The Next JDA

The following article originally appeared at MLBTradeRumors.com on November 29, 2013. With the recent suspensions of Dee Gordon and Chris Colabello, the subject of PED incentives has once again entered the spotlight. Although the post initially addresses the situation of a player reaching the free agent market after a positive PED test, it represents an effort to consider functional punishments for a variety of scenarios by attempting to distinguish between players in different situations in setting PED disincentives.

Gordon, of course, is in the first season of a five-year extension. The general rule framework proposed below would result in a much greater financial loss than his actual suspension will cause him, which arguably provides a stronger disincentive — all while limiting the skewing of team incentives and market function to the extent possible. Read the full post below:

We’ve all seen the range of responses to the four-year, $53MM deal that Jhonny Peralta inked with the Cardinals right on the heels of serving a fifty game suspension for violating the performance enhancing substances prohibitions contained in the league’s Joint Drug Prevention and Treatment Program (JDA). Rather than rehash them here, or take a moral stand in one way or another, I’d like to look at things from a practical perspective.

By guaranteeing four years at over $13MM per, the contract went well beyond the biggest multi-year deals given to other players recently hit with a suspension just before hitting free agency. That doesn’t change the moral calculus, but it does highlight that — as MLBTR’s Steve Adams has explained — teams may not be substantially reducing their valuation of a player based on his past usage of PEDs. Though clubs may factor in some negative PR value, discount past performance during periods of use, or add in a bit of an additional risk adjustment, the net just isn’t that great.

Peralta may well have landed his deal because of his steady production and defense at a position in great demand on the present market, rather than his PED use. But he just as surely did not lose his deal because of the banned substances that he took.

This matters most, it seems to me, because of what it says about incentives. Teams’ market-driven decision-making is apparently not going to provide a significant disincentive on its own. And the fact is, as Cards’ GM John Mozeliak correctly points out“at this point in the game, there’s nothing that says [Peralta] can’t go play or isn’t free to go sign with another club.”

And, arguably, neither is the JDA itself doing enough to shift the PED equation. Like all punitive systems, the JDA sets up upon negatives incentives to outweigh positive incentives to engage in the behavior it wishes to prohibit. As Diamondbacks reliever and union rep Brad Ziegler said on Twitter: “We thought 50 games would be a deterrent. Obviously it’s not.”

This may be somewhat overstated: the shaming effect (especially given the shift in player sentiment) and suspension process seem to be having at least some effect, as most observers acknowledge that PED usage is not nearly as rampant as it once was. On the other hand, Ziegler is definitely on to something. At least for some players, in some situations, the benefits to using PEDs outweigh the drawbacks — even, perhaps, if they are caught. The meager weight of the current suspension system, I think, is the most worrying lesson from the Peralta deal.

Viewed in its worst light, the suspension system creates a mental process much like the kitchen table scene in Office Space. Playing the devil on the shoulder of his would-be co-conspirators, Peter Gibbons seals their agreement to skim cash from their hated employer by dismissing the downside: “This isn’t Riyadh. … The worst they would ever do is they would put you for a couple of months into a white-collar, minimum-security resort!”

But is it really the case that the use of banned substances could, in some cases, present only de minimus downside for a player? Is Ziegler right that Peralta shows that “it pays to cheat”?

In some ways, that certainly could be the case. Players who get caught with their hand in the cookie jar often claim they used PEDs to help recover from injury, not to artificially boost performance. Now that we’re past the era of cartoonishly outsized sluggers, that may even be the most common and impactful use of PEDs. You know, just getting back to a player’s regular level of production and giving him a chance to demonstrate his value at an opportune time. Sure, he may pay for it later by giving up fifty games worth of salary. But the chance to, say, highlight performance before hitting free agency, or jump at an early-career MLB opportunity, can often be invaluable to a ballplayer.

So, assuming that a blanket ban on the list of disallowed PEDs is in fact the goal — putting aside, in other words, the debate on their use in injury rehab — it seems to me that a more thoughtful disincentive system is plainly needed. As a baseline, it is important to recognize that PED prohibition is an agreed-upon rule of the game, and its enforcement is as much about fairness to clean players (and to fans) as it is about keeping dirty players from using to their own long-term health detriment.

Click below to see my conceptual proposal for some methods that might be employed, individually or in concert, to arrive at a more effective system of PED disincentives. These include: eliminating suspensions altogether; varying punishment based upon service time and/or contract status; and utilizing financial disincentives while minimizing impact on competition and the market.

Read more

MLBTR Podcast With Guest Chuck Wasserstrom

On this week’s show, Chuck Wasserstrom joins the show to share some of his experiences as a veteran of the Cubs’ front office and how it has shaped his writing for MLBTR and other outlets.

Click here to subscribe to the podcast on iTunes, and please leave a review! The podcast is also available via Stitcher at this link.

The MLB Trade Rumors Podcast runs weekly on Thursday afternoons.